MedPath

Fetal Alcohol Damage Prevention Study

Not Applicable
Completed
Conditions
Fetal Alcohol Syndrome
Substance Abuse
Registration Number
NCT00696085
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The goal of this study was to determine whether a series of blood markers of alcohol use obtained from alcohol using pregnant women could help them to change their behavior.

Detailed Description

This study involved screening pregnant women with an alcoholism screening questionnaire and obtaining blood from those women who screened positive and a subset of women who screened negative. Each woman who had blood drawn were informed of their results, educated about alcohol use in pregnancy and had a brief intervention about their alcohol use, if appropriate. They were monitored throughout the pregnancy with additional blood tests obtained, depending upon their stage in pregnancy. After birth the babies were examined for any signs of alcohol exposure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
612
Inclusion Criteria
  • Pregnant women seen at one of the obstetric clinics in the study and willing to give a blood sample
Exclusion Criteria
  • over 36 week gestation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Decrease in drinkingduring the pregnancy
Secondary Outcome Measures
NameTimeMethod
improved infant sizeafter pregnancy finished

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.